BR112013010272A2 - métodos analíticos e arranjos para uso nos mesmos - Google Patents

métodos analíticos e arranjos para uso nos mesmos

Info

Publication number
BR112013010272A2
BR112013010272A2 BR112013010272A BR112013010272A BR112013010272A2 BR 112013010272 A2 BR112013010272 A2 BR 112013010272A2 BR 112013010272 A BR112013010272 A BR 112013010272A BR 112013010272 A BR112013010272 A BR 112013010272A BR 112013010272 A2 BR112013010272 A2 BR 112013010272A2
Authority
BR
Brazil
Prior art keywords
arrangements
analytical methods
analytical
methods
Prior art date
Application number
BR112013010272A
Other languages
English (en)
Other versions
BR112013010272B1 (pt
Inventor
Ann-Sofie Albrekt
Carl A K Borrebaeck
Henrik Johansson
Malin Lindstedt
Original Assignee
Senzagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senzagen Ab filed Critical Senzagen Ab
Publication of BR112013010272A2 publication Critical patent/BR112013010272A2/pt
Publication of BR112013010272B1 publication Critical patent/BR112013010272B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
BR112013010272-1A 2010-10-26 2011-10-26 métodos analíticos e arranjos para uso nos mesmos BR112013010272B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018014.9A GB201018014D0 (en) 2010-10-26 2010-10-26 Analytical methods and arrays for use in the same
GB1018014.9 2010-10-26
PCT/GB2011/052082 WO2012056236A2 (en) 2010-10-26 2011-10-26 Analytical methods and arrays for use in the same

Publications (2)

Publication Number Publication Date
BR112013010272A2 true BR112013010272A2 (pt) 2016-09-13
BR112013010272B1 BR112013010272B1 (pt) 2021-03-09

Family

ID=43365491

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013010272-1A BR112013010272B1 (pt) 2010-10-26 2011-10-26 métodos analíticos e arranjos para uso nos mesmos

Country Status (17)

Country Link
US (3) US20130274134A1 (pt)
EP (1) EP2633077B1 (pt)
KR (2) KR102115317B1 (pt)
CN (2) CN103429756B (pt)
BR (1) BR112013010272B1 (pt)
CA (1) CA2815892C (pt)
CY (1) CY1119262T1 (pt)
DK (1) DK2633077T3 (pt)
ES (1) ES2639406T3 (pt)
GB (1) GB201018014D0 (pt)
HR (1) HRP20171281T1 (pt)
LT (1) LT2633077T (pt)
PL (1) PL2633077T3 (pt)
PT (1) PT2633077T (pt)
RS (1) RS56230B1 (pt)
SI (1) SI2633077T1 (pt)
WO (1) WO2012056236A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201207297D0 (en) 2012-04-26 2012-06-06 Senzagen Ab Analytical methods and arrays for use in the same
EP2743344A1 (en) 2012-12-11 2014-06-18 DCPrime B.V. Therapeutic cancer vaccines derived from a novel dendritic cell line
GB201421207D0 (en) * 2014-11-28 2015-01-14 Senzagen Ab Analytical methods and arrays for use in the same
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
EP3536805B1 (en) 2016-03-23 2022-11-02 SenzaGen AB Analytical methods and arrays for use in the same
CN107189988B (zh) * 2017-07-17 2019-08-30 江南大学 一株分泌抗丁香酚单克隆抗体的杂交瘤细胞株cs12及其应用
GB201715445D0 (en) 2017-09-25 2017-11-08 Senzagen Ab Novel cell line and uses thereof
EP3803415A1 (en) * 2018-06-04 2021-04-14 Avon Products, Inc. Protein biomarkers for identifying and treating aging skin and skin conditions
KR102372647B1 (ko) * 2019-08-16 2022-03-10 성균관대학교산학협력단 멜라닌 형성 검출용 조성물 및 피부 미백 물질의 스크리닝 방법
US20220334130A1 (en) * 2019-08-16 2022-10-20 Research & Business Foundation Sungkyunkwan University Melanogenesis detection method using fam86a
KR102531515B1 (ko) * 2019-08-16 2023-05-15 성균관대학교산학협력단 Fam86a 억제제를 유효성분으로 포함하는 멜라닌 결핍 질환의 예방, 치료, 또는 개선용 조성물
CN110794047A (zh) * 2019-09-30 2020-02-14 广州市华代生物科技有限公司 一种复杂受试物对皮肤致敏性的预测方法
CN111879950B (zh) * 2020-08-11 2021-05-25 苏州大学附属第二医院 Ddrgk1作为预测胃癌患者使用铂类化疗药物预后的分子标志物的应用
EP4363604A1 (en) * 2021-06-30 2024-05-08 Ampel Biosolutions, LLC Methods and systems for machine learning analysis of inflammatory skin diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12586T1 (de) 1980-05-02 1985-04-15 Edward P Davis Beinentlastungsgeraet.
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
EP2294412A1 (en) * 2008-06-04 2011-03-16 Ceetox Inc. Method for predicting skin sensitizing activity of compounds
AT507402A1 (de) * 2008-09-16 2010-04-15 Arc Austrian Res Centers Gmbh Verfahren zur prüfung des irritierenden oder allergenen potentials eines produkts

Also Published As

Publication number Publication date
ES2639406T3 (es) 2017-10-26
CN108624675A (zh) 2018-10-09
US20170218449A1 (en) 2017-08-03
CA2815892C (en) 2021-10-19
CY1119262T1 (el) 2018-02-14
GB201018014D0 (en) 2010-12-08
WO2012056236A2 (en) 2012-05-03
KR20140001919A (ko) 2014-01-07
HRP20171281T1 (hr) 2017-10-20
KR102115317B1 (ko) 2020-05-26
CN103429756B (zh) 2018-06-05
RS56230B1 (sr) 2017-11-30
EP2633077A2 (en) 2013-09-04
LT2633077T (lt) 2017-07-25
BR112013010272B1 (pt) 2021-03-09
SI2633077T1 (sl) 2017-10-30
KR20190016624A (ko) 2019-02-18
KR101948904B1 (ko) 2019-02-15
CA2815892A1 (en) 2012-05-03
PT2633077T (pt) 2017-09-08
WO2012056236A3 (en) 2012-06-21
DK2633077T3 (en) 2017-08-07
PL2633077T3 (pl) 2017-11-30
US20130274134A1 (en) 2013-10-17
CN103429756A (zh) 2013-12-04
EP2633077B1 (en) 2017-06-07
US20210189497A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
BR112013010272A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BR112013018656A2 (pt) sistemas e métodos para maximização de uso de amostra
BR112013007506A2 (pt) piridinonas/pirazinonas - métodos de criação e de uso
CO6821883A2 (es) Nuevos moduladores y métodos para su uso
BR112014018136A2 (pt) anticorpos ou uso e método para determinar
BR112013003304A2 (pt) composição lubrificante e composição lubrificante para uso em condições externas
BR112014007789A2 (pt) sistemas e métodos para análise biológica
BR112013008410A2 (pt) sistema para uso em reparação tecidual
BR112012031232A2 (pt) método, dispositivo e uso
BR112012025697A2 (pt) "dispositivo e método para conjunto estrutural"
BR112012005807A2 (pt) materiais expansíveis e mpetodos para uso
BR112012031446A2 (pt) componentes e métodos para implantes
BR112012017441A2 (pt) compostos e métodos
BR112013009069A2 (pt) instrumentação unida ao paciente e métodos
BR112013013249A2 (pt) método e dispositivo para dobrar painéis
BR112013012480A2 (pt) bebida esportiva para aumento de desempenho e métodos de uso
CO6920293A2 (es) Compuestos antibaterianos y método para su uso
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BR112012000534A2 (pt) métodos e composições para uso em terapias celulares
BR112013006868A2 (pt) aparelho espaçador interespinhoso para fixação e métodos de uso
BR112013013250A2 (pt) método e dispositivo para dobrar painéis
BR112013001423A2 (pt) método, método in vitro, uso e kit útil para realizar o método
BR112014033053A2 (pt) aparelho e método para uso em poços delgados
CO6781486A2 (es) Compuestos y su uso
BR112013006131A2 (pt) inibidores de notum pectinacetilesterase e métodos para sua utilização

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SENZAGEN AB (SE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/10/2011, OBSERVADAS AS CONDICOES LEGAIS.